<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24970">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01792414</url>
  </required_header>
  <id_info>
    <org_study_id>HC12143</org_study_id>
    <nct_id>NCT01792414</nct_id>
  </id_info>
  <brief_title>Transcranial Electrical Stimulation (TES) for the Treatment of Depression.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of New South Wales</source>
  <oversight_info>
    <authority>Australia: UNSW Human Research Ethics Committee</authority>
    <authority>Australia: Department of Health and Ageing Therapeutic Goods Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a RCT of transcranial electrical stimulation in depressed patients. Mood,
      cognitive test performance and biomarkers will be measured during the trial.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Montgomery Asberg Depression Rating Scale for Depression (MADRS)</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory II</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Major Depression</condition>
  <arm_group>
    <arm_group_label>Active TES</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active TES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham TES</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham TES</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham TES</intervention_name>
    <description>Neuroconn Eldith device</description>
    <arm_group_label>Sham TES</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active TES</intervention_name>
    <description>Neuroconn Eldith device</description>
    <arm_group_label>Active TES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV Major Depressive Episode (as part of a Major Depressive Disorder or  Bipolar
             Disorder), of minimum 4 weeks duration.

          -  MADRS score â‰¥ 20 at study entry.

        Exclusion Criteria:

          -  DSM-IV psychotic disorder;

          -  drug or alcohol abuse or dependence (preceding 12 months);

          -  inadequate response to ECT (current episode of depression);

          -  anticonvulsant or benzodiazepine medication;

          -  rapid clinical response required, e.g. high suicide risk; clinically defined
             neurological disorder or insult;

          -  metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash)
             at proposed electrode sites;

          -  pregnancy.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Angelo Alonzo, PhD</last_name>
    <phone>61-2-93823720</phone>
    <email>a.alonzo@unsw.edu.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>Black Dog Institute / University of New South Wales</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelo Alonzo, PhD</last_name>
      <phone>61-2-93823720</phone>
      <email>a.alonzo@unsw.edu.au</email>
    </contact>
    <contact_backup>
      <last_name>Donel Martin, PhD</last_name>
      <phone>61-2-93829261</phone>
      <email>donel.martin@unsw.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Colleen Loo, MBBS, FRANZCP, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>February 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of New South Wales</investigator_affiliation>
    <investigator_full_name>Colleen Loo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
